Four High-Impact Studies, One Powerful Platform — Rocgene Archimed X4
Cutting-Edge Research Powered by Rocgene Archimed X4
Recent studies by leading researchers have utilized the Rocgene Archimed X4, a next- generation analytical platform supporting advances in biomedical research. Recent publications have showcased its versatility across diverse research frontiers.
| Title | Journal | Latest Impact Factor |
| Oral administration of asparagine and 3-indolepropionic acid prolongs survival time of rats with traumatic colon injury Click Here | Military Medical Research | 22.9 |
| Programming conformational cooperativity to regulate allosteric protein-oligonucleotide signal transduction Click Here | Nature Communications | 15.7 |
| All-Trans-Retinoic Acid-Adjuvanted mRNA Vaccine Induces Mucosal Anti-Tumor Immune Responses for Treating Colorectal Cancer Click Here | Advanced Science | 14.1 |
| Two-Stage Mixed-Dye-Based Isothermal Amplification with Ribonuclease-Cleavable Enhanced Probes for Dual-Visualization Detection of SARS-CoV-2 Variants of Interest Click Here | Advanced Science | 14.1 |
Each of these studies exemplifies how the Archimed X4 empowers precision, reproducibility, and speed in complex biological analyses.